Biovance
For Patients
Biovance

HOMEABOUT 3LORDERING INFORMATIONINSURANCE SUPPORTCONNECT WITH USSAFETY INFORMATIONLOG INSIGN UP

Menu

HOME

ABOUT BIOVANCE•3L

ORDERING INFORMATION

INSURANCE SUPPORT

CONNECT WITH US

LOG IN

SIGN UP

Safety Information

SAFETY INFORMATION

BIOVANCE•3L is pure human amniotic tissue
with an intact basement membrane1

Devoid of cells, hormones, growth factors and cytokines

Cell attachment is a natural stimulus for the orderly release of growth factors and cytokines

Serves as a cell-friendly structure for cell attachment within hours

Within 24 hours, cells readily attached to BIOVANCE, but not dHACM1

In in vitro data, BIOVANCE served as an inert scaffold with an intact basement membrane that supported a high level of fibroblast and keratinocyte attachment vs dHACM, which had no attachment of either cell type

Fibroblasts that attach to and grow on BIOVANCE release growth factors in vitro that support wound closure1

  • Growth factors, among other key molecules released by attached fibroblasts, may support key events in wound healing such as cell survival, wound closure, and angiogenic blood vessel formation
  • Once growth factors were released, measured cell metabolic activity showed the revival of senescent endothelial cells and keratinocytes

REFERENCE: 1. Bhatia M, Pereira M, Rana H, Stout B, Lewis C, Abramson S. The mechanism of cell interaction and response on decellularized human amniotic membrane: Implications in wound healing. Wounds. 2007;19(8):207-217.

Celularity

PRIVACY POLICY         TERMS OF USE         SAFETY INFORMATION

PRIVACY POLICY

TERMS OF USE

SAFETY INFORMATION

BIOVANCE® and Celularity® are registered trademarks of Celularity Inc.
© 2021 Celularity Inc.

BIOVANCE® and Celularity® are registered trademarks of Celularity Inc. © 2021 Celularity Inc